Rilzabrutinib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Rilzabrutinib
Treatment and conditionWhere it standsTrials
Rilzabrutinib for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1